<DOC>
	<DOCNO>NCT01051583</DOCNO>
	<brief_summary>Assess efficacy Avastin adjunct Diode Laser cyclophotocoagulation treatment Neovascular Glaucoma .</brief_summary>
	<brief_title>Avastin Adjunct Diode Laser Treatment Neovascular Glaucoma</brief_title>
	<detailed_description>Design : Prospective , comparative interventional case series . Method : Patients randomly assign Group A treat Diode laser cyclophotocoagulation alone , whereas group B receive intravitreal Avastin ( One milligram = 0.04mL 25 mg/mL ) conjunction Diode Laser . The preoperative data include etiology , mean age ; follow period , full ophthalmological examination emphasis mean IOP , iris neovascularization , pain corneal edema .</detailed_description>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Neovascular</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>Neovascular absolute glaucoma Painful blind eye Neovascular glaucoma useful vision potential useful vision</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>72 Years</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Neovascular glaucoma</keyword>
	<keyword>diode laser</keyword>
	<keyword>cyclophotocoagulation</keyword>
	<keyword>Avastin</keyword>
</DOC>